Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387556 · ClinicalTrials.gov registry record · NA
Ondansetron Reduce Vomiting Associated With Ketamine PSA
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 268
- Enrollment target
NCT00387556 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 268 participants.
The verdict
NCT00387556, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
Study Summary
Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.
Interventions
- DRUG Ondansetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2002-12 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00387556
The ClinicalTrials.gov registry entry for NCT00387556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ondansetron is the first listed.
NCT00387556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00387556 about?
NCT00387556 is a clinical study titled "Ondansetron Reduce Vomiting Associated With Ketamine PSA". Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.
What is the current status of trial NCT00387556?
This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2002-12. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00387556?
The interventions under investigation include: Ondansetron (DRUG).
Who is sponsoring clinical trial NCT00387556?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.